Generics Bulletin is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GGB Awards Set Stage For Milan In October

Entries Are Now Open Ahead Of 9 October Awards Ceremony In Milan

Executive Summary

The Global Generics & Biosimilars Awards returns to Milan this October, recognizing the top achievements across the generics, biosimilars and value added medicines industries. Entries are now open and you can also book tickets to attend, both of which are free of charge.

Entries are now open for the Global Generics & Biosimilars Awards 2024, which this year returns to Milan, Italy, on Wednesday 9 October, during CPhI Worldwide week.

Now in their eleventh year, the awards – which are free to enter and attend, with our prizegiving ceremony taking place in-person at the Hotel NH Milano Fiera – celebrate the greatest achievements across the generics, biosimilars and value added medicines industries.

Entries are open until Monday 22 July and can cover any activities undertaken between 1 September 2023 and 31 July 2024.

Backed by headline sponsor IQVIA and Company of the Year – Americas category sponsor Cerba Research, the awards are also supported by International Health Partners in our Corporate Social Responsibility Initiative of the Year category.

Other categories will include our company of the year award and our two other regional company of the year awards for the Asia-Pacific and EMEA regions; acquisition of the year; active pharmaceutical ingredient supplier of the year; biosimilar initiative of the year; and business development of the year.

Meanwhile, further awards will recognize the best campaign of the year; the leading industry partner; regulatory achievement of the year; value added medicine initiative of the year; and leader of the year.

“We can’t wait to be back in Milan to celebrate the top achievements across the entire global generics, biosimilars and value added medicines industry,” commented Dave Wallace, executive editor of Generics Bulletin. “As the off-patent industry continues to play a key part in contributing value to healthcare systems worldwide, while also expanding access to essential medicines, we’re proud to be flying the flag for the companies and individuals leading these achievements.”

The Global Generics & Biosimilars Awards prides itself on its independence, with winners chosen solely on merit and acknowledged as most deserving for their unique achievements. All submissions will be reviewed by an independent panel of expert judges, selected for their industry knowledge and impartiality.

For a full list of the awards categories, submissions criteria, how to attend and other information, go here.

To enquire about sponsorship opportunities, please e-mail [email protected]

And to register interest in attending the Global Generics & Biosimilars Awards 2024, to receive the latest updates and for any further details, please e-mail [email protected]

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

GB153314

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel